TNNT2 and melanoma: Levels of hs-cTnT ≥ 7 ng/L were independent predictors of all-cause mortality in a large, heterogeneous study in terms of malignancies examined (breast and gastrointestinal cancers, multiple myeloma, and melanoma) [28].